Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VPHM - Viropharma Inc -- Ignore unavailable to you. Want to Upgrade?

To: T-Lo Greens who wrote (70)	7/14/1999 1:26:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 2557

zinc medications have not proven themselves in subsequent clinical testing. that aside, it's irrelevant...... are you going to go to the FDA and ask to run a prophylaxis trial for the common cold? No, as you'd be asked for the name of the planet that you were visiting from. you daytrading jerks don't know what it means to reduce the duration of disease for a viral infection when therapy is initiated after symptoms have occurred. This is a major accomplishment. Moreover, if you knew squat about plec's mechanism and additional trial data, you'd be sweating.